ArticleJournal for immunotherapy of cancer2019

Optimized fractionated radiotherapy with anti-PD-L1 and anti-TIGIT: a promising new combination.

Mathieu Grapin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.